Ads
related to: jak inhibitors list of drugs- Treatment Information
Find Information For
An AS Treatment Option.
- Mechanism Of Action
View MOA Information For An
Ankylosing Spondylitis Treatment.
- Treatment Info - HCPs
Find Info On A Non-Radiographic
Axial Spondyloarthritis Treatment.
- Contact A Rep
Contact A Rep To Learn About An
AS Treatment Option. HCP Site.
- Physical Function - HCPs
Visit To Learn More About
Clinical Trial Data. HCP Site.
- Support & Resources
View Support & Resources
For An AS Treatment.
- Treatment Information
Prescription-treatment-website.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
A Janus kinase inhibitor, also known as JAK inhibitor or jakinib, [1] is a type of immune modulating medication, which inhibits the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway in lymphocytes.
Janus kinase 3 inhibitors, also called JAK3 inhibitors, are a new class of immunomodulatory agents that inhibit Janus kinase 3. They are used for the treatment of autoimmune diseases . The Janus kinases are a family of four nonreceptor tyrosine-protein kinases, JAK1 , JAK2 , JAK3 , and TYK2 .
Tyrosine kinase inhibitor (TKI) with selective activity against RET, VEGFR-2 and EGFR: Medullary thyroid cancer. Diarrhoea, hypertension, QT interval prolongation, depression, electrolyte anomalies, hypothyroidism and GI perforation (uncommon). 2.3 mTOR inhibitors: Everolimus: PO: mTOR inhibitor.
[8] [9] [10] It is a janus kinase (JAK) inhibitor, [8] [9] discovered and developed by the National Institutes of Health and Pfizer. Common side effects include diarrhea, headache, and high blood pressure. [10] Serious side effects may include infections, cancer, and pulmonary embolism.
Janus kinase (JAK) is a family of intracellular, non-receptor tyrosine kinases that transduce cytokine-mediated signals via the JAK-STAT pathway. They were initially named " just another kinase " 1 and 2 (since they were just two of many discoveries in a PCR -based screen of kinases), [ 1 ] but were ultimately published as "Janus kinase".
If JAK inhibitors can show similarly impressive results, gain approval, and make a splash, then these blockbuster biologics could have some real competition. While the future is promising that "if ...
ATC code L01 Antineoplastic agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
For premium support please call: 800-290-4726 more ways to reach us
Ads
related to: jak inhibitors list of drugsPrescription-treatment-website.com has been visited by 10K+ users in the past month